Dainippon Sumitomo Pharma Co., Ltd. Receives Approval For Orally Disintegrating Formulation Of Amlodin, Hypertension/Angina Pectoris Treatment

Tokyo, Mar 20, 2006 (JCN) - Dainippon Sumitomo Pharma announced on March 17 that it has received approval for its proprietary ethical drugs, Amlodin OD Tablet 2.5mg/ 5mg, from the Ministry of Health, Labor and Welfare as of March 15.